Rv2203/MT2259 is a protein that, as the name suggests, has not been fully characterized . The recombinant form of this protein is often produced in host organisms such as E. coli for research purposes .
| Feature | Description |
|---|---|
| Official Full Name | Uncharacterized protein Rv2203/MT2259 (Rv2203, MT2259) |
| UniProt ID | P64949 |
| Species | Human |
| Source | E. coli |
| Tag | His-tagged |
| Protein Length | Full Length (1-230 amino acids) |
| Form | Lyophilized powder |
| Purity | Greater than 85% as determined by SDS-PAGE |
| Storage | Store at -20°C/-80°C upon receipt, aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles. |
| Storage Buffer | Tris/PBS-based buffer, 6% Trehalose, pH 8.0 |
| Reconstitution | Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. Adding 5-50% of glycerol (final concentration) is recommended for long-term storage at -20℃/-80℃. |
The recombinant protein is produced in E. coli and tagged with Histidine (His) to facilitate purification . The protein's molecular weight is approximately 135 kDa, and it exhibits a multimeric structure comprising trimers and hexamers, which can bind to the ACE2 receptor .
While the specific function of Rv2203/MT2259 remains uncharacterized, studies suggest its involvement in various pathways and interactions with other proteins and molecules . Identifying interacting proteins is achieved through methods like yeast two-hybrid assays, co-immunoprecipitation (co-IP), and pull-down assays .
Rv2203/MT2259 is found in Mycobacterium tuberculosis (Mtb) . Research indicates that proteins like Rv1417 and Rv2617c interact with the exported repetitive protein (Erp), a virulence factor in Mtb . These interactions are linked to bacterial replication and preventing bacterial injury from oxidative stress . Understanding these interactions could provide insights into new antitubercular compounds that might bind to Rv1636 .
Rv2203 (also designated as MT2259) is a possible membrane protein found in Mycobacterium tuberculosis. It is classified as part of the cell wall and cell processes functional category, with the following key characteristics:
| Feature | Description |
|---|---|
| Product | Possible membrane protein |
| Feature Type | CDS |
| Genomic Position | 2468231-2468923 |
| Strand | + |
| Length | 693 nucleotides |
| Amino Acid Length | 230 residues |
| Transcription Factor | FALSE |
The protein is currently labeled as "uncharacterized" because its precise biological function has not been fully elucidated . Bioinformatic analysis suggests it contains transmembrane domains consistent with membrane localization, supporting its annotation as a probable membrane protein.
Recombinant Rv2203 can be produced using several expression systems, each with advantages and limitations:
| Expression System | Advantages | Considerations |
|---|---|---|
| E. coli | High yield, cost-effective, rapid expression | May form inclusion bodies requiring refolding, potential issues with membrane protein folding |
| Yeast | Better for membrane proteins, eukaryotic post-translational modifications | Longer expression time, more complex media requirements |
| Baculovirus | Excellent for membrane proteins, high yields | More technically demanding, higher cost |
| Mammalian cell lines | Most authentic post-translational modifications | Lower yields, highest cost, longest expression time |
| Cell-free expression | Avoids toxicity issues, direct access to reaction conditions | Lower yields, higher cost per mg protein |
For structural studies, E. coli or cell-free expression systems are commonly used, while functional studies may benefit from expression in eukaryotic systems. All systems typically achieve ≥85% purity as determined by SDS-PAGE .
Rv2203 appears to be subject to specific regulatory controls within the M. tuberculosis genome. Research indicates:
It is predicted to be co-regulated in modules bicluster_0084 (with residual 0.58) and bicluster_0253 (with residual 0.45)
This regulation may be mediated by de-novo identified cis-regulatory motifs with e-values of 0.64 and 170.00 for bicluster_0084, and 18.00 and 8,100.00 for bicluster_0253
These modules show enrichment for GO terms related to nucleobase-containing compound kinase activity
The gene has been identified as relevant for growth on cholesterol, suggesting potential involvement in lipid metabolism pathways
Although global transcription analysis studies of M. tuberculosis have been conducted, specific expression data for Rv2203 under different conditions requires further investigation . Researchers examining Rv2203 regulation should consider analyzing its expression patterns during different growth phases, nutrient limitations, and exposure to host-relevant stresses.
Purifying membrane proteins like Rv2203 presents specific challenges. Based on current methodologies for similar mycobacterial membrane proteins, the following purification strategy is recommended:
Extraction optimization: Use a detergent screening approach to identify optimal solubilization conditions (common detergents include DDM, LDAO, and C12E8)
Initial purification: Immobilized metal affinity chromatography (IMAC) using the His-tag present in recombinant constructs
Intermediate purification: Ion exchange chromatography to remove contaminants
Polishing step: Size exclusion chromatography to achieve high purity and remove protein aggregates
Quality control: Assess purity using SDS-PAGE (target ≥85% purity) and verify identity by mass spectrometry
For challenging applications requiring higher purity, additional chromatography steps may be necessary. For membrane proteins like Rv2203, maintaining the protein in appropriate detergent micelles throughout purification is critical for stability and function .
Given that Rv2203 remains uncharacterized, several complementary approaches can be used to investigate its function:
Genetic manipulation:
Phenotypic characterization:
Assess growth in different media conditions, particularly those containing cholesterol
Examine cell wall integrity and composition
Test susceptibility to various antibiotics, particularly those targeting cell envelope
Evaluate survival under stress conditions (oxidative, acidic, nutrient limitation)
Transcriptomic and proteomic analysis:
Compare gene expression profiles between wild-type and Rv2203 mutant strains
Identify proteins that interact with Rv2203 using pull-down assays coupled with mass spectrometry
Examine changes in the membrane proteome in Rv2203 mutants
Structural biology approaches:
Determine the 3D structure using X-ray crystallography or cryo-EM
Perform molecular dynamics simulations to predict functional domains
These approaches should be integrated to build a comprehensive understanding of Rv2203's role in M. tuberculosis biology .
Understanding the interaction partners of Rv2203 is crucial for elucidating its function. Several complementary techniques can be employed:
Co-immunoprecipitation (Co-IP):
Express epitope-tagged Rv2203 in M. tuberculosis
Solubilize membranes with appropriate detergents
Pull down Rv2203 complexes and identify interacting partners by mass spectrometry
Bacterial two-hybrid systems:
Adapt systems for membrane proteins (such as BACTH)
Screen against a library of M. tuberculosis proteins
Validate positive interactions with secondary assays
Proximity-dependent labeling:
Fuse Rv2203 to BioID or APEX2
Express in mycobacteria and allow proximity labeling
Identify labeled proteins by streptavidin pulldown and mass spectrometry
Surface plasmon resonance (SPR):
Use purified recombinant Rv2203 immobilized on sensor chips
Test interaction with candidate proteins identified from other methods
Determine binding kinetics and affinity constants
Chemical crosslinking coupled with mass spectrometry:
Apply membrane-permeable crosslinkers to intact cells or membrane preparations
Enrich for Rv2203-containing complexes
Identify crosslinked peptides by specialized mass spectrometry techniques
For membrane proteins like Rv2203, detergent selection is critical for maintaining native interactions during these experiments.
While direct evidence linking Rv2203 to virulence is limited, several lines of investigation could reveal its potential role in pathogenesis:
Infection models:
Compare wild-type and Rv2203 mutant strains in macrophage infection assays
Assess bacterial survival, replication, and host cell responses
Evaluate performance in animal models (mice, guinea pigs) if in vitro results are promising
Host-pathogen interaction:
Investigate whether Rv2203 interacts with specific host factors
Determine if it modulates host immune responses or cellular processes
Assess its role in bacterial adaptation to the host environment
Expression analysis during infection:
Monitor Rv2203 expression levels during different stages of infection
Compare expression in active vs. latent infection models
Identify conditions that upregulate or downregulate the gene
Since Rv2203 is a membrane protein associated with cell wall processes, it may play roles in:
Maintaining cell envelope integrity under host stress conditions
Participating in nutrient acquisition (particularly cholesterol metabolism)
Contributing to cell wall remodeling during different infection phases
Potential immune evasion mechanisms
Systematic investigation using these approaches would help define Rv2203's contribution to M. tuberculosis pathogenesis .
To ensure recombinant Rv2203 preparations represent the native protein in both structure and function, several validation methods should be implemented:
Structural validation:
Circular dichroism (CD) spectroscopy to confirm secondary structure elements
Thermal shift assays to assess protein stability
Limited proteolysis to identify folded domains
Mass spectrometry to verify protein mass and potential modifications
Functional validation:
Reconstitution into liposomes to assess membrane integration
Binding assays with potential ligands (particularly cholesterol-related compounds)
Activity assays if enzymatic function is predicted
Complementation studies in Rv2203 knockout strains
Quality control metrics:
Size-exclusion chromatography coupled with multi-angle light scattering (SEC-MALS) to assess oligomeric state
Dynamic light scattering (DLS) to evaluate sample homogeneity
Negative-stain electron microscopy to visualize protein particles
For recombinant membrane proteins like Rv2203, validation should include verification that the protein has been correctly inserted into detergent micelles or membrane mimetics with the expected topology .
Recombinant Rv2203 protein has several potential applications in both basic and translational tuberculosis research:
Diagnostic development:
Evaluate Rv2203 as a potential biomarker for TB infection
Develop antibodies against Rv2203 for immunodiagnostic applications
Assess presence of anti-Rv2203 antibodies in patient sera as diagnostic indicators
Vaccine research:
Test Rv2203 as a potential antigen in subunit vaccine formulations
Evaluate immune responses to Rv2203 in animal models
Determine if Rv2203-specific immune responses correlate with protection
Drug target validation:
Develop high-throughput screening assays using recombinant Rv2203
Identify small molecules that bind Rv2203 and disrupt its function
Validate hits using structure-function studies and in vivo efficacy models
Structural biology:
Determine the 3D structure to inform rational drug design
Identify potential binding pockets for small molecule inhibitors
Use structure to predict functional mechanisms
Immunological research:
Characterize host immune responses to Rv2203
Determine if Rv2203 modulates host immune function
Investigate potential antigenic properties for immune detection
Since Rv2203 appears to be involved in cholesterol utilization, which is critical for M. tuberculosis persistence in the host, it represents a potentially attractive target for therapeutic development aimed at disrupting this important metabolic pathway .